Literature DB >> 27781369

Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome.

I M Fuentes1, J A Christianson2.   

Abstract

Ion channels are expressed throughout the gastrointestinal system and regulate nearly every aspect of digestion, including fluid secretion and absorption, motility, and visceral sensitivity. It is therefore not surprising that in the setting of functional bowel disorders, such as irritable bowel syndrome (IBS), ion channels are often altered in terms of expression level and function and are a target of pharmacological intervention. This is particularly true of their role in driving abdominal pain through visceral hypersensitivity (VH), which is the main reason IBS patients seek medical care. In the study by Scanzi et al., in the current issue of this journal, they provide evidence that the T-type voltage-gated calcium channel (Cav ) Cav 3.2 is upregulated in human IBS patients, and is necessary for the induction of an IBS-like disease state in mice. In this mini-review, we will discuss the contribution of specific ion channels to VH in IBS, both in human patients and rodent models. We will also discuss how Cav 3.2 may play a role as an integrator of multiple environmental stimuli contributing toward VH.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990TRPzzm321990; ion channels; irritable bowel syndrome; microbiome; serotonin; visceral hypersensitivity

Mesh:

Substances:

Year:  2016        PMID: 27781369      PMCID: PMC5123675          DOI: 10.1111/nmo.12979

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  51 in total

1.  Control of intestinal motility by the Ca(v)1.2 L-type calcium channel in mice.

Authors:  Jörg W Wegener; Verena Schulla; Angela Koller; Norbert Klugbauer; Robert Feil; Franz Hofmann
Journal:  FASEB J       Date:  2006-04-24       Impact factor: 5.191

2.  Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.

Authors:  Arthur Beyder; Amelia Mazzone; Peter R Strege; David J Tester; Yuri A Saito; Cheryl E Bernard; Felicity T Enders; Weronica E Ek; Peter T Schmidt; Aldona Dlugosz; Greger Lindberg; Pontus Karling; Bodil Ohlsson; Maria Gazouli; Gerardo Nardone; Rosario Cuomo; Paolo Usai-Satta; Francesca Galeazzi; Matteo Neri; Piero Portincasa; Massimo Bellini; Giovanni Barbara; Michael Camilleri; G Richard Locke; Nicholas J Talley; Mauro D'Amato; Michael J Ackerman; Gianrico Farrugia
Journal:  Gastroenterology       Date:  2014-03-05       Impact factor: 22.682

Review 3.  Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain.

Authors:  P Holzer
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

4.  The expression of protease-activated receptor 2 and 4 in the colon of irritable bowel syndrome patients.

Authors:  Ju-hui Zhao; Lei Dong; Hai-tao Shi; Zong-yan Wang; Hong-yang Shi; Hui Ding
Journal:  Dig Dis Sci       Date:  2011-07-29       Impact factor: 3.199

5.  Effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia.

Authors:  Adrian Miranda; Shachar Peles; Peter G McLean; Jyoti N Sengupta
Journal:  Pain       Date:  2006-07-17       Impact factor: 6.961

6.  Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats.

Authors:  S M O'Mahony; V D Felice; K Nally; H M Savignac; M J Claesson; P Scully; J Woznicki; N P Hyland; F Shanahan; E M Quigley; J R Marchesi; P W O'Toole; T G Dinan; J F Cryan
Journal:  Neuroscience       Date:  2014-08-01       Impact factor: 3.590

Review 7.  Roles of transient receptor potential channels in pain.

Authors:  Cheryl L Stucky; Adrienne E Dubin; Nathaniel A Jeske; Sacha A Malin; David D McKemy; Gina M Story
Journal:  Brain Res Rev       Date:  2008-12-31

8.  Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial.

Authors:  Gary Tabas; Mary Beaves; Jiping Wang; Paul Friday; Houssam Mardini; George Arnold
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

9.  Hydrogen sulfide as a novel nociceptive messenger.

Authors:  Atsufumi Kawabata; Tsuyoshi Ishiki; Keita Nagasawa; Shigeru Yoshida; Yumi Maeda; Tomoko Takahashi; Fumiko Sekiguchi; Tetsuyuki Wada; Seiji Ichida; Hiroyuki Nishikawa
Journal:  Pain       Date:  2007-03-07       Impact factor: 6.961

10.  Involvement of the Cav3.2 T-type calcium channel in thalamic neuron discharge patterns.

Authors:  Yi-Fang Liao; Meng-Li Tsai; Chien-Chang Chen; Chen-Tung Yen
Journal:  Mol Pain       Date:  2011-06-04       Impact factor: 3.395

View more
  12 in total

1.  Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies.

Authors:  Maria Maddalena Cavalluzzi; Roberta Budriesi; Maria Antonietta De Salvia; Laura Quintieri; Monica Piarulli; Gualtiero Milani; Roberta Gualdani; Matteo Micucci; Ivan Corazza; Antonio Rosato; Maurizio Viale; Leonardo Caputo; Carlo Franchini; Giovanni Lentini
Journal:  Pharmacol Rep       Date:  2020-10-19       Impact factor: 3.024

Review 2.  Measurement of novel intestinal secretory and barrier pathways and effects of proteases.

Authors:  Adam L Edwinson; Madhusudan Grover
Journal:  Neurogastroenterol Motil       Date:  2019-04       Impact factor: 3.598

Review 3.  Nociceptive Roles of TRPM2 Ion Channel in Pathologic Pain.

Authors:  Yongwoo Jang; Pyung Sun Cho; Young Duk Yang; Sun Wook Hwang
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

Review 4.  Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies.

Authors:  Michael Camilleri; Alexandra Zhernakova; Isotta Bozzarelli; Mauro D'Amato
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-08-10       Impact factor: 73.082

5.  Stereotaxic Exposure of the Central Nucleus of the Amygdala to Corticosterone Increases Colonic Permeability and Reduces Nerve-Mediated Active Ion Transport in Rats.

Authors:  Priya Hattay; Dawn K Prusator; Anthony C Johnson; Beverley Greenwood-Van Meerveld
Journal:  Front Neurosci       Date:  2018-08-07       Impact factor: 4.677

6.  The extracellular matrix glycoprotein tenascin-X regulates peripheral sensory and motor neurones.

Authors:  Rubina Aktar; Madusha Peiris; Asma Fikree; Vincent Cibert-Goton; Maxim Walmsley; Iain R Tough; Paulo Watanabe; Eduardo J A Araujo; Sahar D Mohammed; Jean-Marie Delalande; David C Bulmer; S Mark Scott; Helen M Cox; Nicol C Voermans; Qasim Aziz; L Ashley Blackshaw
Journal:  J Physiol       Date:  2018-07-18       Impact factor: 5.182

7.  Effects of red ginseng on gut, microbiota, and brain in a mouse model of post-infectious irritable bowel syndrome.

Authors:  Seonhye Yu; Eunho Chun; Yeounjung Ji; Young Joo Lee; Mirim Jin
Journal:  J Ginseng Res       Date:  2021-04-03       Impact factor: 6.060

8.  Enteric nervous system modulation of luminal pH modifies the microbial environment to promote intestinal health.

Authors:  M Kristina Hamilton; Elena S Wall; Catherine D Robinson; Karen Guillemin; Judith S Eisen
Journal:  PLoS Pathog       Date:  2022-02-10       Impact factor: 6.823

9.  In Silico Study Approach on a Series of 50 Polyphenolic Compounds in Plants; A Comparison on the Bioavailability and Bioactivity Data.

Authors:  Amalia Stefaniu; Lucia Camelia Pirvu
Journal:  Molecules       Date:  2022-02-19       Impact factor: 4.411

Review 10.  The Pivotal Role of TRP Channels in Homeostasis and Diseases throughout the Gastrointestinal Tract.

Authors:  Alessandro Alaimo; Josep Rubert
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.